Canaccord Genuity Maintains Buy on Aspen Aerogels, Raises Price Target to $28
Portfolio Pulse from Benzinga Newsdesk
Canaccord Genuity analyst George Gianarikas maintains a Buy rating on Aspen Aerogels (ASPN) and raises the price target from $18 to $28.
May 03, 2024 | 9:16 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Canaccord Genuity has maintained a Buy rating on Aspen Aerogels and increased the price target from $18 to $28.
The increase in price target by Canaccord Genuity reflects a positive outlook on Aspen Aerogels, likely due to strong fundamentals or growth prospects. This endorsement from a reputable analyst could lead to increased investor confidence and a potential rise in ASPN's stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100